Back to results
US 8,557,843 B2Granted
Quinoline derivatives and their use as tyrosine kinase inhibitors
AssigneeClanotech AB
InventorsJacob Westman, Natalia Nekhotiaeva, Johan Wannberg, Ulrika Backman, Johan Malm
Life of this patent
Estimating the term…
Abstract
A compound of formula (I) as well as pharmaceutically acceptable salts thereof. A pharmaceutical composition having a therapeutically effective amount of the compound. The compound is useful for the treatment of cancer, diabetic retinopathy, age-related macular degeneration, inflammation, stroke, ischemic myocardium, atherosclerosis, macular edema or psoriasis.
Claims6
The compound:
- 4-[(4-methoxyphenyl)amino]-6-(methylcarbamoyl)quinoline-3-carboxylic acid, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.